Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO-B) Stock Ticker

NYSE: BIO-B · Healthcare · Medical - Devices
$374.59-1.29%
USD · as of 2026-11-03 · market cap $10.0B
Open BIO-B in TickrDownload for iPhone

Market factors today

Tickr 500 vs S&P 500-0.52%-0.5% MTD
Momentum L/S-6.39%-6.4% MTD
High-beta momo L/S-7.29%-7.3% MTD
Rate sensitivity L/S+6.55%+6.5% MTD
Oil sensitivity L/S-3.93%-3.9% MTD
Unprofitable tech-4.05%-4.0% MTD

Unlock the full BIO-B picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on BIO-B
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.

BIO-B stock facts

Ticker symbolBIO-B
ExchangeNew York Stock Exchange
SectorHealthcare
IndustryMedical - Devices
Market cap$10.0B
CEONorman D. Schwartz
Employees7,450
HeadquartersHercules, CA, US
IPO date1999-09-21
Websitewww.bio-rad.com

What you can see for BIO-B on Tickr

Live BIO-B price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BIO-B report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Bio-Rad Laboratories, Inc.?

The ticker symbol for Bio-Rad Laboratories, Inc. is BIO-B, listed on the New York Stock Exchange.

What is BIO-B?

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and…

HomeExploreMarketLists
All pages